Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hospital

Addicted to Learning: Can We Teach as Well (& Enthrallingly!) as Fortnite?

Philip Seo, MD, MHS  |  April 15, 2019

My nephew is an addict. These words do not come easily to me, but I have come to accept them as true. In retrospect, I should have recognized the telltale signs: He stopped picking up the phone when I call. He disappears and then re-emerges hours later, seemingly having done nothing. He has lost interest…

Filed under:Education & TrainingOpinionRheuminationsSpeak Out Rheum Tagged with:augmented realitymassive open online course (MOOC)virtual reality

kenary820 / shutterstock.com

Rheumatology Drugs at a Glance, Part 1: Psoriatic Arthritis

Mary Choy, PharmD, BCGP, FASHP  |  April 15, 2019

Over the past few years, biosimilars and other new drugs have been introduced to treat rheumatic illnesses. Some of the conditions we treat have numerous drug options, others have few or only off-label options. This series, Rheumatology Drugs at a Glance, provides streamlined information on the administration of biologic, biosimilar and other medications used to…

Filed under:ConditionsDrug UpdatesPsoriatic Arthritis Tagged with:abataceptadalimumabapremilastbrodalumabCertolizumab PegoletanerceptGolimumabinfliximabixekizumabPsoriatic ArthritisRheumatic Drugs at a GlancesecukinumabTofacitinibtreatment guidelinesustekinumab

Japan Approves Risankizumab for Psoriasis & Psoriatic Arthritis

Michele B. Kaufman, PharmD, BCGP  |  April 15, 2019

Japan has approved risankizumab for treating plaque psoriasis, generalized pustular psoriasis, erythrodermic psoriasis and psoriatic arthritis in adults…

Filed under:Biologics/DMARDsDrug Updates Tagged with:JapanPsoriasisPsoriatic Arthritisrisankizumab

Metrics in Rheumatology: Focus on Harold E. (Hal) Paulus, MD

Gretchen Henkel  |  April 11, 2019

We have just learned that Dr. Hal Paulus passed away on April 5, 2019. We are reposting this story today in his memory and will share additional information as we learn it.

Filed under:ConditionsProfilesResearch Rheum Tagged with:CareerPatientsPaulusResearchTraining

Mirikizumab Promising for Plaque Psoriasis

Michele B. Kaufman, PharmD, BCGP  |  April 10, 2019

During a 16-week study, patients with plaque psoriasis taking mirikizumab experienced higher response rates and skin clearance compared with placebo…

Filed under:Biologics/DMARDsDrug Updates Tagged with:mirikizumabplaque psoriasisskin

For Psoriasis, Ustekinumab & TNF Inhibitors Show Similar Cardiac Safety

David Douglas  |  April 9, 2019

NEW YORK (Reuters Health)—In patients with psoriasis and psoriatic arthritis, the incidence of atrial fibrillation and major adverse cardiovascular events does not differ between treatment with ustekinumab and TNF inhibitors, according to a large observational study. “Given a high cardiovascular risk among patients with psoriasis and psoriatic arthritis,” Seoyoung C. Kim, MD, ScD, MSCE, told…

Filed under:Conditions Tagged with:cardiovascularcardiovascular eventPsoriasisPsoriatic ArthritisSafetyTNF inhibitorustekinumab

Health Canada Approves Adalimumab for Chronic Non-Infectious Anterior Uveitis in Pediatric Patients

Michele B. Kaufman, PharmD, BCGP  |  April 3, 2019

Health Canada has approved adalimumab for treating chronic non-infectious anterior uveitis in patients 2 years and older…

Filed under:Biologics/DMARDsConditionsDrug UpdatesPediatric Conditions Tagged with:adalimumabnon-infectious anterior uveitisPediatricUveitis

In It Together: Peer-Support Programs Help Physicians After Stressful Events

Carina Stanton  |  April 3, 2019

A formal peer-support program for medical providers affected by stress and trauma is gradually becoming a cultural norm for rheumatologists and other physicians at Johns Hopkins University…

Filed under:Practice Support

Carpal Tunnel Syndrome of Pregnancy May Persist Long After Delivery

Megan Brooks  |  March 27, 2019

NEW YORK (Reuters Health)—About 15% of women who develop carpal tunnel syndrome (CTS) while pregnant will suffer persistent and worsening symptoms long after delivery, a new study suggests. “Conventional medical wisdom has been that gestational carpal tunnel syndrome simply goes away after pregnancy, and for many women this is true. However, in our practice this…

Filed under:Conditions Tagged with:Carpal Tunnel Syndromegestational CTSpregnancypregnancy complicationspregnant womenWomen

Women Diagnosed Years Later than Men for Same Diseases

Tamara Mathias  |  March 27, 2019

(Reuters Health)—For a wide range of diseases, diagnosis comes later in life for women than for men, according to a large Danish study. Researchers don’t know whether the later diagnoses are due to genetics, the environment, possible biases in the healthcare system—or some combination of reasons. The study of health data from 6.9 million Danish…

Filed under:Conditions Tagged with:DiagnosisWomen

  • « Previous Page
  • 1
  • …
  • 127
  • 128
  • 129
  • 130
  • 131
  • …
  • 323
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences